Incyte
INCY
#1035
Rank
HK$180.41 B
Marketcap
HK$890.07
Share price
0.59%
Change (1 day)
33.96%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): HK$63.53

According to Incyte's latest financial reports the company's current EPS (TTM) is HK$63.80. In 2025 the company made an earnings per share (EPS) of HK$51.79 an increase over its 2024 EPS that were of HK$2.43.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$63.5322.65%
2025HK$51.792029.03%
2024HK$2.43-88.39%
2023HK$20.9573.38%
2022HK$12.09-64.1%
2021HK$33.67-408.63%
2020-HK$10.91-166.83%
2019HK$16.32300%
2018HK$4.08-133.33%
2017-HK$12.24-378.57%
2016HK$4.392700%
2015HK$0.16-106.67%
2014-HK$2.35-44.44%
2013-HK$4.2450%
2012-HK$2.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$52.27-18.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-90.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$234.52 267.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.29 99.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$78.55 23.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.86-101.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-HK$4.55-107.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-HK$6.59-110.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$1.73-102.71%๐Ÿ‡บ๐Ÿ‡ธ USA